trapidil has been researched along with Hyperplasia in 1 studies
Trapidil: A coronary vasodilator agent.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tiell, ML | 1 |
| Sussman, II | 1 |
| Gordon, PB | 1 |
| Saunders, RN | 1 |
1 other study available for trapidil and Hyperplasia
| Article | Year |
|---|---|
Suppression of fibroblast proliferation in vitro and of myointimal hyperplasia in vivo by the triazolopyrimidine, Trapidil.
Topics: Animals; Aorta; Cell Division; Cells, Cultured; Fibroblasts; Hyperplasia; In Vitro Techniques; Male; | 1983 |